JP5159117B2 - Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 - Google Patents
Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 Download PDFInfo
- Publication number
- JP5159117B2 JP5159117B2 JP2007032319A JP2007032319A JP5159117B2 JP 5159117 B2 JP5159117 B2 JP 5159117B2 JP 2007032319 A JP2007032319 A JP 2007032319A JP 2007032319 A JP2007032319 A JP 2007032319A JP 5159117 B2 JP5159117 B2 JP 5159117B2
- Authority
- JP
- Japan
- Prior art keywords
- coenzyme
- water
- soluble organic
- organic solvent
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims description 154
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 title claims description 71
- 239000002245 particle Substances 0.000 title claims description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 235000017471 coenzyme Q10 Nutrition 0.000 title description 5
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title description 2
- 229940110767 coenzyme Q10 Drugs 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 93
- 239000003960 organic solvent Substances 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 60
- 239000007864 aqueous solution Substances 0.000 claims description 39
- 238000003756 stirring Methods 0.000 claims description 29
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 description 28
- 239000013078 crystal Substances 0.000 description 24
- 238000005469 granulation Methods 0.000 description 24
- 230000003179 granulation Effects 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 15
- 235000013305 food Nutrition 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 12
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 238000003825 pressing Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 8
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 8
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 6
- MXLMTQWGSQIYOW-UHFFFAOYSA-N 3-methyl-2-butanol Chemical compound CC(C)C(C)O MXLMTQWGSQIYOW-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- PFNHSEQQEPMLNI-UHFFFAOYSA-N 2-methyl-1-pentanol Chemical compound CCCC(C)CO PFNHSEQQEPMLNI-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 229940035429 isobutyl alcohol Drugs 0.000 description 4
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 4
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 150000004292 cyclic ethers Chemical class 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 2
- JNAYPRPPXRWGQO-UHFFFAOYSA-N 2-chloropropanenitrile Chemical compound CC(Cl)C#N JNAYPRPPXRWGQO-UHFFFAOYSA-N 0.000 description 2
- NWPNXBQSRGKSJB-UHFFFAOYSA-N 2-methylbenzonitrile Chemical compound CC1=CC=CC=C1C#N NWPNXBQSRGKSJB-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- RFFFKMOABOFIDF-UHFFFAOYSA-N Pentanenitrile Chemical compound CCCCC#N RFFFKMOABOFIDF-UHFFFAOYSA-N 0.000 description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- -1 pharmaceutical Substances 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- IAHFWCOBPZCAEA-UHFFFAOYSA-N succinonitrile Chemical compound N#CCCC#N IAHFWCOBPZCAEA-UHFFFAOYSA-N 0.000 description 2
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 1
- 150000004057 1,4-benzoquinones Chemical class 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- UZSGWJQJDLCCFN-UHFFFAOYSA-N 2-acetylbenzonitrile Chemical compound CC(=O)C1=CC=CC=C1C#N UZSGWJQJDLCCFN-UHFFFAOYSA-N 0.000 description 1
- AEQBTIZIDSFIGT-UHFFFAOYSA-N 2-bromo-6-methylbenzonitrile Chemical compound CC1=CC=CC(Br)=C1C#N AEQBTIZIDSFIGT-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- AFMPMSCZPVNPEM-UHFFFAOYSA-N 2-bromobenzonitrile Chemical compound BrC1=CC=CC=C1C#N AFMPMSCZPVNPEM-UHFFFAOYSA-N 0.000 description 1
- PYNYHMRMZOGVML-UHFFFAOYSA-N 2-bromopropanenitrile Chemical compound CC(Br)C#N PYNYHMRMZOGVML-UHFFFAOYSA-N 0.000 description 1
- NHWQMJMIYICNBP-UHFFFAOYSA-N 2-chlorobenzonitrile Chemical compound ClC1=CC=CC=C1C#N NHWQMJMIYICNBP-UHFFFAOYSA-N 0.000 description 1
- DTNSDCJFTHMDAK-UHFFFAOYSA-N 2-cyanobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C#N DTNSDCJFTHMDAK-UHFFFAOYSA-N 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- XMVLVJWAJIDMSY-UHFFFAOYSA-N 2-ethylbutan-1-ol;4-methylpentan-2-ol Chemical compound CCC(CC)CO.CC(C)CC(C)O XMVLVJWAJIDMSY-UHFFFAOYSA-N 0.000 description 1
- QKPVEISEHYYHRH-UHFFFAOYSA-N 2-methoxyacetonitrile Chemical compound COCC#N QKPVEISEHYYHRH-UHFFFAOYSA-N 0.000 description 1
- FSTPMFASNVISBU-UHFFFAOYSA-N 2-methoxybenzonitrile Chemical compound COC1=CC=CC=C1C#N FSTPMFASNVISBU-UHFFFAOYSA-N 0.000 description 1
- SWBDKCMOLSUXRH-UHFFFAOYSA-N 2-nitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC=CC=C1C#N SWBDKCMOLSUXRH-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- XDJAAZYHCCRJOK-UHFFFAOYSA-N 4-methoxybenzonitrile Chemical compound COC1=CC=C(C#N)C=C1 XDJAAZYHCCRJOK-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002529 anti-mitochondrial effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZTOMUSMDRMJOTH-UHFFFAOYSA-N glutaronitrile Chemical compound N#CCCCC#N ZTOMUSMDRMJOTH-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000011361 granulated particle Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- AILKHAQXUAOOFU-UHFFFAOYSA-N hexanenitrile Chemical compound CCCCCC#N AILKHAQXUAOOFU-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- RAMPDACRJWTXEV-UHFFFAOYSA-N methyl 2-cyanobenzoate Chemical compound COC(=O)C1=CC=CC=C1C#N RAMPDACRJWTXEV-UHFFFAOYSA-N 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- PLZZPPHAMDJOSR-UHFFFAOYSA-N nonanenitrile Chemical compound CCCCCCCCC#N PLZZPPHAMDJOSR-UHFFFAOYSA-N 0.000 description 1
- YSIMAPNUZAVQER-UHFFFAOYSA-N octanenitrile Chemical compound CCCCCCCC#N YSIMAPNUZAVQER-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- XQZYPMVTSDWCCE-UHFFFAOYSA-N phthalonitrile Chemical compound N#CC1=CC=CC=C1C#N XQZYPMVTSDWCCE-UHFFFAOYSA-N 0.000 description 1
- 229920006391 phthalonitrile polymer Polymers 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
本発明は、還元型補酵素Q10を含有する補酵素Q10粒子の製造方法に関する。還元型補酵素Q10は、酸化型補酵素Q10と比較して高い経口吸収性を示し、優れた、食品、栄養機能食品、特定保健用食品、栄養補助剤、栄養剤、動物薬、飲料、飼料、化粧品、医薬品、治療薬、予防薬等として有用な化合物である。 The present invention relates to a process for producing coenzyme Q 10 particles containing reduced coenzyme Q 10. Reduced coenzyme Q 10 shows a comparison with a high oral absorbability and oxidized coenzyme Q 10, excellent, food, food with nutrient function claims, food for specified health use, nutritional supplement, nutritional, animal drug, drink These compounds are useful as feeds, cosmetics, pharmaceuticals, therapeutic agents, preventive agents, and the like.
広く生物界に分布することが知られているベンゾキノン誘導体である酸化型補酵素Q10は、そのビタミン様の機能からビタミンQとも呼ばれており、弱った細胞活性を健康な状態に戻す栄養源として身体を若返らせる成分である。一方、還元型補酵素Q10は、酸化型補酵素Q10の2電子還元体であり、酸化型補酵素Q10が橙色結晶であるのに対し、還元型補酵素Q10は白色結晶である。還元型補酵素Q10及び酸化型補酵素Q10は、ミトコンドリア、リソゾーム、ゴルジ体、ミクロソーム、ペルオキシソーム、或いは細胞膜などに局在し、電子伝達系の構成成分としてATP産生賦活、生体内での抗酸化作用、膜安定化に関与している事が知られている生体の機能維持に必要不可欠な物質である。 Widely oxidized coenzyme Q 10 is a benzoquinone derivative which is known to be distributed in the living world, the is also called vitamin Q from vitamin-like function, nutrient return the weakened cell activity in healthy It is a component that rejuvenates the body. On the other hand, reduced coenzyme Q 10 is a two-electron reduction of oxidized coenzyme Q 10, whereas the oxidized coenzyme Q 10 is an orange crystal, reduced coenzyme Q 10 is a white crystalline . Reduced coenzyme Q 10 and oxidized coenzyme Q 10, anti-mitochondrial, lysosomal, golgi, microsomes, peroxisomes, or the like localized cell membrane, ATP production activation as constituents of the electron transport system in vivo It is an indispensable substance for maintaining the functions of living organisms that are known to be involved in oxidation and membrane stabilization.
還元型補酵素Q10は、例えば、合成、発酵、天然物からの抽出等の従来公知の方法により補酵素Q10を得た後、クロマトグラフィーにより流出液中の還元型補酵素Q10区分を濃縮する方法等により得られることが知られている(特許文献1)。しかしながら、このようにして得られる還元型補酵素Q10は、必ずしも純度が高い状態では取得できず、例えば、酸化型補酵素Q10をはじめとする不純物を含有する低純度結晶や油状物、半固体状として得られやすい。 Reduced coenzyme Q 10 is, for example, synthetic, fermentation, after obtaining coenzyme Q 10 by a conventionally known method such as extraction from natural products, the reduced coenzyme Q 10 divided in the effluent by chromatography It is known that it can be obtained by a method of concentrating (Patent Document 1). However, reduced coenzyme Q 10 thus obtained can not necessarily acquire a high purity state, for example, low-purity crystals or oil containing impurities, including oxidized coenzyme Q 10, half It is easy to obtain as a solid.
本発明者らは、鋭意検討の結果、高品質の還元型補酵素Q10を得るための製法を確立し、特許出願を行っている(特許文献2〜5)。しかしながら、特許文献2に記載された方法では、結晶が微細で、スラリーや結晶の性状が悪く、晶析濃度が高めにくい、撹拌しにくい、晶析缶から払い出しにくい、濾過性が悪くて結晶分離に時間かかる、嵩比重が小さく梱包容器の大型化や個数の増加につながるといった、生産性や操作性の問題があった。特許文献3に記載された方法では、上記特許文献2で触れた問題は幾分か改善されてはいるものの、十分とは言いがたい。また、特許文献4に記載された方法では、攪拌翼や缶壁にスケーリングを起こしやすい、数cm程度の造粒体が生成する上に、粒度分布が非常に広いといった問題を抱えている。さらに、特許文献5に記載された方法では、比較的粒度分布は狭まるものの、条件によっては、数μm程度の造粒体が得られたり、或いは数mm超の造粒体が得られたりと、適当な粒子径に調製するのが難しい。また、比較的固い造粒体が得られる場合もある。 The present inventors have intensive studies results, establishing a method for obtaining reduced coenzyme Q 10 of high quality, have filed a patent application (Patent Document 2-5). However, in the method described in Patent Document 2, the crystal is fine, the properties of the slurry and the crystal are poor, the crystallization concentration is difficult to increase, it is difficult to stir, it is difficult to remove from the crystallization can, the filterability is poor, and the crystal is separated. There is a problem of productivity and operability such that it takes time, and the bulk specific gravity is small, leading to an increase in the size and number of packaging containers. In the method described in Patent Document 3, the problem mentioned in Patent Document 2 is somewhat improved, but it is not sufficient. In addition, the method described in Patent Document 4 has a problem that a granulated body of about several centimeters that easily causes scaling on a stirring blade and a can wall is generated, and the particle size distribution is very wide. Furthermore, in the method described in Patent Document 5, although the particle size distribution is relatively narrow, depending on conditions, a granulated body of about several μm is obtained, or a granulated body of more than several mm is obtained, It is difficult to prepare an appropriate particle size. Moreover, a comparatively hard granulated body may be obtained.
得られた造粒体あるいは結晶の粒子径が小さすぎる場合、大きすぎる場合、あるいは粒子径の大小を問わず造粒体や結晶の固い場合には、それぞれに問題点を抱えている。粒子径が小さい場合には、造粒体あるいは結晶の流動性等の物性が悪いため、取り扱いに難がある。一方、造粒体の粒子径が大きい場合、あるいは、固い場合には、食品、栄養機能食品、特定保健用食品、栄養補助剤、栄養剤、動物薬、飲料、飼料、化粧品、医薬品、治療薬、予防薬等に加工する際、大きい粒子径の造粒体が残存し、求められる品質とならない可能性がある。例えば、食品用途に加工する際には、還元型補酵素Q10の分布に偏りが生じ、均一にならないことも考えられる。また、医薬品、栄養機能食品、特定保健用食品等の用途に錠剤・カプセル剤等の製剤に加工しようとした場合、固さ、粒子径の影響で製剤化できないことも考えられる。
本発明は、上記に鑑み、流動性等の粉体物性を改善し、かつ、食品、栄養機能食品、特定保健用食品、栄養補助剤、栄養剤、動物薬、飲料、飼料、化粧品、医薬品、治療薬、予防薬等に加工しやすい適当な固さと粒子径を持つ還元型補酵素Q10を含有する補酵素Q10造粒体を得るための、工業的規模での製造に適した製造方法を提供することを目的とする。 In view of the above, the present invention improves powder physical properties such as fluidity, and food, nutritional functional food, food for specified health use, nutritional supplement, nutritional supplement, animal medicine, beverage, feed, cosmetics, pharmaceutical, therapeutic agent, for obtaining coenzyme Q 10 granular material containing reduced coenzyme Q 10 with workable suitable hardness and particle diameter prophylactic etc., manufacturing method suitable for manufacturing on an industrial scale The purpose is to provide.
本発明者らは、上記課題を解決すべく鋭意研究した結果、還元型補酵素Q10を含有する補酵素Q10を、水溶性有機溶媒に特定の濃度となるように溶解させた溶液を、水溶性有機溶媒と水の混合溶媒中に添加することにより、例えば100〜1000μm程度の、適度な粒子径を持つ補酵素Q10の造粒体が得られることがわかった。 The present inventors have made intensive studies to solve the above problems, the coenzyme Q 10 containing reduced coenzyme Q 10, the solution was dissolved at a particular concentration in a water-soluble organic solvent, by adding in a mixed solvent of a water-soluble organic solvent and water, for example, about 100 to 1000 [mu] m, granulated form of the coenzyme Q 10 with an appropriate particle size is found to result.
すなわち、本発明は、
還元型補酵素Q10を含有する補酵素Q1030〜80重量%と、水溶性有機溶媒70〜20重量%からなる補酵素Q10溶液(A)を、
25℃以下の水溶性有機溶媒の水溶液(B)中に、
添加することを特徴とする補酵素Q10粒子の製造方法、
である。
That is, the present invention
And coenzyme Q 10 30 to 80 wt% containing reduced coenzyme Q 10, coenzyme Q 10 solution consisting of 70 to 20% by weight of a water-soluble organic solvent (A),
In an aqueous solution (B) of a water-soluble organic solvent at 25 ° C. or lower,
A method for producing coenzyme Q 10 particles, characterized by comprising:
It is.
本発明の方法によれば、攪拌翼や缶壁へのスケーリングを起こすことなく、また、均一でかつ適度な堅さと粒子径を持った還元型補酵素Q10粒子、または、還元型補酵素Q10を含有する補酵素Q10粒子を製造することができる。 According to the method of the present invention, reduced coenzyme Q 10 particles or reduced coenzyme Q having uniform and appropriate hardness and particle size without causing scaling to a stirring blade or a can wall. Coenzyme Q 10 particles containing 10 can be produced.
以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明の補酵素Q10粒子(造粒体)の製造方法においては、還元型補酵素Q10を含有する補酵素Q1030〜80重量%と水溶性有機溶媒70〜20重量%からなる補酵素Q10溶液(A)を、25℃以下の水溶性有機溶媒の水溶液(B)中に、添加することを特徴とする。 In the method for producing coenzyme Q 10 particles of the present invention (granules), consisting of coenzyme Q 10 30 to 80 wt% and a water-soluble organic solvents 70 to 20 wt% containing reduced coenzyme Q 10 coenzyme the enzyme Q 10 solution (a), in 25 ° C. solution of the following water-soluble organic solvent (B), is characterized by adding.
本発明の製造方法においては、少なくとも還元型補酵素Q10を含有する補酵素Q10が対象となる。その場合、補酵素Q10は、還元型補酵素Q10単独でも良く、又、酸化型補酵素Q10と還元型補酵素Q10との混合物であっても良い。上記混合物の場合、還元型補酵素Q10の補酵素Q10の総量(すなわち、還元型補酵素Q10及び酸化型補酵素Q10の合計量)に占める割合は、特に制限されないが、例えば10重量%以上、普通30重量%以上、好ましくは50重量%以上、より好ましくは70重量%以上、とりわけ90重量%以上、なかんずく96重量%以上である。上限は100重量%であり、特に限定されないが、普通99.9重量%以下である。補酵素Q10中の酸化型補酵素Q10の割合が高い場合は、水溶性有機溶媒に対する溶解性が低下し、補酵素Q10溶液(A)を高濃度に調製することが困難になる傾向があるため、本発明の製造方法においては、補酵素Q10中の還元型補酵素Q10の割合が高い方が好ましい。以下、本明細書において、「補酵素Q10」と記載した場合は、還元型補酵素Q10単独の場合は還元型補酵素Q10そのものを、酸化型補酵素Q10と還元型補酵素Q10との混合物である場合はその混合物全体を意味する。 In the production method of the present invention, coenzyme Q 10 containing at least reduced coenzyme Q 10 is of interest. In that case, coenzyme Q 10 is reduced coenzyme Q 10 alone may also be a mixture of oxidized coenzyme Q 10 and reduced coenzyme Q 10. For the mixtures, the ratio to the total amount of coenzyme Q 10 reduced coenzyme Q 10 (i.e., the total amount of reduced coenzyme Q 10 and oxidized coenzyme Q 10) is not particularly limited, for example, 10 % By weight, usually 30% by weight or more, preferably 50% by weight or more, more preferably 70% by weight or more, especially 90% by weight or more, especially 96% by weight or more. Although an upper limit is 100 weight% and is not specifically limited, Usually, it is 99.9 weight% or less. If the ratio of oxidized coenzyme Q 10 in coenzyme Q 10 is high, the solubility is lowered to the water-soluble organic solvent, comprising coenzyme Q 10 solution (A) is difficult to prepare a high concentration tends because there is, in the manufacturing method of the present invention, it is preferable that a high proportion of reduced coenzyme Q 10 in coenzyme Q 10. Hereinafter, in the present specification, when “coenzyme Q 10 ” is described, when reduced coenzyme Q 10 is used alone, reduced coenzyme Q 10 itself is referred to as oxidized coenzyme Q 10 and reduced coenzyme Q 10. When it is a mixture with 10, it means the whole mixture.
本発明で使用する還元型補酵素Q10、または還元型補酵素Q10を含有する補酵素Q10は、例えば、合成、発酵、天然物からの抽出等の従来公知の方法により得ることができる。好ましくは、既存の高純度補酵素Q10など酸化型補酵素Q10、あるいは酸化型補酵素Q10と還元型補酵素Q10の混合物を、一般的な還元剤、例えば、ハイドロサルファイトナトリウム(次亜硫酸ナトリウム)、水素化ホウ素ナトリウム、アスコルビン酸類等を用いて還元することにより得られたもの(還元型の濃度を高めたものも含む)であり、より好ましくは、既存の高純度補酵素Q10など酸化型補酵素Q10、あるいは酸化型補酵素Q10と還元型補酵素Q10の混合物を、アスコルビン酸類を用いて還元することにより得られたものである。 Reduced coenzyme Q 10 used in the present invention or coenzyme Q 10 containing reduced coenzyme Q 10, can, for example, synthetic, fermentation can be obtained by a conventionally known method such as extraction from natural products . Preferably, a mixture of existing highly pure coenzyme Q 10, etc. oxidized coenzyme Q 10 or oxidized coenzyme Q 10 and reduced coenzyme Q 10,, common reducing agents, e.g., sodium hydrosulfite ( Sodium hyposulfite), sodium borohydride, ascorbic acid, and the like (including those having a reduced concentration), and more preferably existing high-purity coenzyme Q. It is obtained by reducing oxidized coenzyme Q 10 such as 10 or a mixture of oxidized coenzyme Q 10 and reduced coenzyme Q 10 using ascorbic acids.
本発明の製造方法においては、以下2種類の溶液を使用する。 In the production method of the present invention, the following two types of solutions are used.
(A)還元型補酵素Q10を含有する補酵素Q1030〜80重量%と、水溶性有機溶媒70〜20重量%からなる補酵素Q10溶液
(B)水溶性有機溶媒と水とを混合した水溶性有機溶媒の水溶液
上記補酵素Q10溶液(A)及び水溶性有機溶媒の水溶液(B)に使用する水溶性有機溶媒としては、特に制限されないが、水に対する溶解度が、普通約50w/w%以上、好ましくは約60w/w%以上、より好ましくは約70w/w%以上、特に好ましくは約80w/w%以上の水溶性有機溶媒である。言うまでもなく、水溶性有機溶媒と水が任意の割合で混合しうる水溶性有機溶媒が最も好ましい。
(A) and coenzyme Q 10 30 to 80 wt% containing reduced coenzyme Q 10, and a coenzyme Q 10 solution (B) a water-soluble organic solvent and water consisting of 70 to 20% by weight of a water-soluble organic solvent The aqueous solution of the mixed water-soluble organic solvent The water-soluble organic solvent used in the coenzyme Q 10 solution (A) and the aqueous solution of the water-soluble organic solvent (B) is not particularly limited, but the solubility in water is usually about 50 w. / W% or more, preferably about 60 w / w% or more, more preferably about 70 w / w% or more, particularly preferably about 80 w / w% or more. Needless to say, a water-soluble organic solvent in which the water-soluble organic solvent and water can be mixed at an arbitrary ratio is most preferable.
そのような水溶性有機溶媒としては、例えば、アルコール類、ケトン類、ニトリル類、環状エーテル類等を挙げることができる。 Examples of such water-soluble organic solvents include alcohols, ketones, nitriles, and cyclic ethers.
上記アルコール類としては、環状、非環状を問わず、又、飽和、不飽和を問わず、特に制限されないが、一般に、飽和のものが好ましく用いられる。普通、炭素数1〜6、特に炭素数1〜5、とりわけ炭素数1〜3の1価アルコールが好ましく、炭素数2〜5の2価アルコールが好ましく、又、炭素数3の3価アルコールが好ましい。 The alcohols are not particularly limited regardless of whether they are cyclic or non-cyclic, and are saturated or unsaturated. In general, saturated alcohols are preferably used. Usually, a monohydric alcohol having 1 to 6 carbon atoms, particularly 1 to 5 carbon atoms, particularly 1 to 3 carbon atoms is preferred, a dihydric alcohol having 2 to 5 carbon atoms is preferred, and a trihydric alcohol having 3 carbon atoms is preferred. preferable.
1価のアルコールとしては、例えば、メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、イソブチルアルコール、tert−ブチルアルコール、1−ペンタノール、2−ペンタノール、3−ペンタノール、2−メチル−1−ブタノール、イソペンチルアルコール、tert−ペンチルアルコール、3−メチル−2−ブタノール、ネオペンチルアルコール、1−ヘキサノール、2−メチル−1−ペンタノール、4−メチル−2−ペンタノール、2−エチル−1−ブタノール、アリルアルコール、プロパルギルアルコール、シクロヘキサノール等を挙げることができる。そのなかで、好ましくは、メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、イソブチルアルコール、tert−ブチルアルコール、1−ペンタノール、2−ペンタノール、3−ペンタノール、2−メチル−1−ブタノール、イソペンチルアルコール、tert−ペンチルアルコール、3−メチル−2−ブタノール、ネオペンチルアルコール、1−ヘキサノール、2−メチル−1−ペンタノール、4−メチル−2−ペンタノール、2−エチル−1−ブタノール、シクロヘキサノールであり、より好ましくは、メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、イソブチルアルコール、tert−ブチルアルコール、1−ペンタノール、2−ペンタノール、3−ペンタノール、2−メチル−1−ブタノール、イソペンチルアルコール、tert−ペンチルアルコール、3−メチル−2−ブタノール、ネオペンチルアルコールであり、さらに好ましくは、メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、イソブチルアルコール、2−メチル−1−ブタノール、イソペンチルアルコールである。 Examples of the monovalent alcohol include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutyl alcohol, tert-butyl alcohol, 1-pentanol, 2-pentanol, and 3-pen. Tanol, 2-methyl-1-butanol, isopentyl alcohol, tert-pentyl alcohol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 4-methyl-2- Examples include pentanol, 2-ethyl-1-butanol, allyl alcohol, propargyl alcohol, and cyclohexanol. Among them, preferably, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutyl alcohol, tert-butyl alcohol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol, isopentyl alcohol, tert-pentyl alcohol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 4-methyl-2-pentanol 2-ethyl-1-butanol, cyclohexanol, more preferably methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutyl alcohol, tert-butyl alcohol, 1-pentanol. , 2- Tertanol, 3-pentanol, 2-methyl-1-butanol, isopentyl alcohol, tert-pentyl alcohol, 3-methyl-2-butanol, neopentyl alcohol, more preferably methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutyl alcohol, 2-methyl-1-butanol, and isopentyl alcohol.
2価のアルコールとしては、1,2−エタンジオール、1,2−プロパンジオール、1,3−プロパンジオール、1,2−ブタンジオール、1,3−ブタンジオール、1,4−ブタンジオール、2,3−ブタンジオール、1,5−ペンタンジオール等を挙げることができる。好ましくは、1,2−エタンジオール、1,2−プロパンジオール、1,3−プロパンジオールであり、より好ましくは、1,2−エタンジオールである。 Examples of the divalent alcohol include 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, , 3-butanediol, 1,5-pentanediol and the like. 1,2-ethanediol, 1,2-propanediol and 1,3-propanediol are preferable, and 1,2-ethanediol is more preferable.
3価のアルコールとしてはグリセリン等を好適に用いることができる。 Glycerin or the like can be suitably used as the trivalent alcohol.
上記アルコール類のうち、1価のアルコールである、メタノール、エタノール、1−プロパノール、2−プロパノールが特に好ましく、エタノールが最も好ましい。 Among the alcohols, methanol, ethanol, 1-propanol, and 2-propanol, which are monovalent alcohols, are particularly preferable, and ethanol is most preferable.
上記ケトン類としては、特に制限されず、普通炭素数3〜6のものが好適に用いられる。その具体例としては、例えば、アセトン、メチルエチルケトン、メチルブチルケトン、メチルイソブチルケトン等を挙げることができ、好ましくは、アセトン、メチルエチルケトンであり、最も好ましくは、アセトンである。 The ketones are not particularly limited, and those having 3 to 6 carbon atoms are preferably used. Specific examples thereof include acetone, methyl ethyl ketone, methyl butyl ketone, methyl isobutyl ketone, and the like, preferably acetone and methyl ethyl ketone, and most preferably acetone.
上記ニトリル類としては、環状、非環状を問わず、又、飽和、不飽和を問わず、特に制限されないが、一般に飽和のものが好ましく用いられる。普通、炭素数2〜8、特に炭素数2〜6、とりわけ炭素数2〜4のものが好適に用いられる。 The nitriles are not particularly limited regardless of whether they are cyclic or non-cyclic, and are saturated or unsaturated. In general, saturated ones are preferably used. Usually, those having 2 to 8 carbon atoms, particularly 2 to 6 carbon atoms, especially 2 to 4 carbon atoms are preferably used.
その具体例としては、例えば、アセトニトリル、プロピオニトリル、マロノニトリル、ブチロニトリル、イソブチロニトリル、スクシノニトリル、バレロニトリル、グルタロニトリル、ヘキサンニトリル、ヘプチルシアニド、オクチルシアニド、クロロアセトニトリル、ブロモアセトニトリル、クロロプロピオニトリル、ブロモプロピオニトリル、メトキシアセトニトリル、シアノ酢酸メチル、シアノ酢酸エチル、トルニトリル、ベンゾニトリル、クロロベンゾニトリル、ブロモベンゾニトリル、シアノ安息香酸、ニトロベンゾニトリル、アニソニトリル、フタロニトリル、ブロモトルニトリル、メチルシアノベンゾエート、メトキシベンゾニトリル、アセチルベンゾニトリル等を挙げることができる。その中で、好ましくは、アセトニトリル、プロピオニトリル、スクシノニトリル、ブチロニトリル、イソブチロニトリル、バレロニトリル、シアノ酢酸メチル、シアノ酢酸エチル、ベンゾニトリル、トルニトリル、クロロプロピオニトリルであり、より好ましくは、アセトニトリル、プロピオニトリル、ブチロニトリル、イソブチロニトリルであり、最も好ましくは、アセトニトリルである。 Specific examples thereof include, for example, acetonitrile, propionitrile, malononitrile, butyronitrile, isobutyronitrile, succinonitrile, valeronitrile, glutaronitrile, hexanenitrile, heptyl cyanide, octyl cyanide, chloroacetonitrile, bromoacetonitrile, chloro Propionitrile, bromopropionitrile, methoxyacetonitrile, methyl cyanoacetate, ethyl cyanoacetate, tolunitrile, benzonitrile, chlorobenzonitrile, bromobenzonitrile, cyanobenzoic acid, nitrobenzonitrile, anisonitrile, phthalonitrile, bromotolunitrile , Methyl cyanobenzoate, methoxybenzonitrile, acetylbenzonitrile and the like. Among them, preferably acetonitrile, propionitrile, succinonitrile, butyronitrile, isobutyronitrile, valeronitrile, methyl cyanoacetate, ethyl cyanoacetate, benzonitrile, tolunitrile, chloropropionitrile, more preferably , Acetonitrile, propionitrile, butyronitrile, isobutyronitrile, and most preferably acetonitrile.
上記環状エーテル類としては、飽和、不飽和を問わず、特に制限されないが、一般に飽和のものが好ましく用いられる。普通、環状エーテルの骨格が3員環〜6員環、好ましくは5員環〜6員環であるものが好適に用いられる。 The cyclic ethers are not particularly limited regardless of whether they are saturated or unsaturated, but generally saturated ones are preferably used. Usually, those having a cyclic ether skeleton of 3 to 6 members, preferably 5 to 6 members are suitably used.
その具体例としては、例えば、1,2−エポキシブタン、ジオキサン、トリオキサン、フラン、2−メチルフラン、テトラヒドロフラン、テトラヒドロピラン、フルフリルアルコール、テトラヒドロフルフリルアルコール等を挙げることができる。好ましくは、ジオキサン、トリオキサン、テトラヒドロフラン、テトラヒドロピランであり、最も好ましくは、テトラヒドロフラン、ジオキサンである。 Specific examples thereof include 1,2-epoxybutane, dioxane, trioxane, furan, 2-methylfuran, tetrahydrofuran, tetrahydropyran, furfuryl alcohol, tetrahydrofurfuryl alcohol, and the like. Preferred are dioxane, trioxane, tetrahydrofuran, and tetrahydropyran, and most preferred are tetrahydrofuran and dioxane.
上記水溶性有機溶媒の中でも、食品、医薬品等の製造に許容される溶媒を用いるのが特に好ましい。 Among the water-soluble organic solvents, it is particularly preferable to use a solvent that is acceptable for the production of foods, pharmaceuticals, and the like.
言うまでもなく、上記水溶性有機溶媒は2種以上を併用しても良い。また、補酵素Q10溶液(A)に使用する水溶性有機溶媒と、水溶性有機溶媒の水溶液(B)に使用する水溶性有機溶媒は、同じであるのが工業上好ましいが、異なっていても何ら差し支えない。補酵素Q10溶液(A)と水溶性有機溶媒の水溶液(B)の少なくともどちらかにおいて、水溶性有機溶媒としてアルコール類を選択するのが好ましく、補酵素Q10溶液(A)と水溶性有機溶媒の水溶液(B)の両方においてアルコール類を選択するのがより好ましい。 Needless to say, two or more water-soluble organic solvents may be used in combination. The water-soluble organic solvent used in the coenzyme Q 10 solution (A) and the water-soluble organic solvent used in the aqueous solution (B) of the water-soluble organic solvent are industrially preferable, but are different. There is no problem. In at least one of the coenzyme Q 10 solution (A) and the water-soluble organic solvent in an aqueous solution (B), it is preferable to select alcohols as the water-soluble organic solvent, coenzyme Q 10 solution (A) and the water-soluble organic It is more preferable to select alcohols in both the aqueous solution (B) of the solvent.
補酵素Q10溶液(A)における補酵素Q10の濃度は、全溶液の重量に対し、30重量%以上、80重量%以下である必要がある。補酵素Q10溶液(A)における補酵素Q10の濃度が30重量%よりも低いときには、得られる造粒体の粒子径が数μm〜数十μm程度と微細になり、通常の晶析と同様のスラリー状となる。一方、補酵素Q10溶液(A)における補酵素Q10の濃度が80重量%よりも高い場合には、1mm超の大きい粒子が得られたり、容易には崩れないほど固い粒子が得られたりする。補酵素Q10溶液(A)における補酵素Q10の濃度は、好ましくは約35%以上、特に好ましくは約40%以上であり、また、好ましくは約75%以下、特に好ましくは約70%以下である。本発明においては、補酵素Q10溶液(A)における補酵素Q10の濃度を上記範囲とすることにより、好ましい粒径と堅さを有する還元型補酵素Q10粒子を製造することが出来る。 Concentration of coenzyme Q 10 in coenzyme Q 10 solution (A) is based on the weight of the total solution, 30 wt% or more, is required to be 80 wt% or less. Coenzyme When Q 10 concentration of coenzyme Q 10 in a solution (A) is less than 30 wt% will become granulated particles diameter of several μm~ several tens μm approximately obtained and fine, the normal crystallization A similar slurry is formed. On the other hand, when the concentration of coenzyme Q 10 in coenzyme Q 10 solution (A) is higher than 80 wt%, or obtained 1mm greater than large particles, easily obtained hard particles as not collapse or To do. Concentration of coenzyme Q 10 in coenzyme Q 10 solution (A) is preferably about 35% or more, particularly at preferably about 40% or more, and preferably about 75% or less, particularly preferably more than about 70% It is. In the present invention, by the concentration of coenzyme Q 10 in coenzyme Q 10 solution (A) within the above range, it is possible to produce a reduced coenzyme Q 10 particles having a preferred particle size and firmness.
補酵素Q10溶液(A)の調製方法としては特に限定されず、還元型補酵素Q10を含有する補酵素Q10と水溶性有機溶媒を上記濃度範囲で混合・溶解することによって調製するのが一般的であるが、酸化型補酵素Q10、あるいは酸化型補酵素Q10を多く含有する補酵素Q10を水溶性有機溶媒に溶解させた後に、還元反応を実施して酸化型補酵素Q10を還元型補酵素Q10に変換させたものを利用しても良い。また、本発明の製造方法で使用される補酵素Q10溶液(A)は、還元型補酵素Q10を含有する補酵素Q10と水溶性有機溶媒からなるものであるが、造粒体形成を妨げない範囲で他の成分を若干量含んでいても構わない。 Is not particularly restricted but a process of preparing the coenzyme Q 10 solution (A), coenzyme Q 10 and a water-soluble organic solvent containing the reduced coenzyme Q 10 for the preparation by mixing and dissolving the above concentration range Although but a general, after dissolving coenzyme Q 10 containing a large amount of oxidized coenzyme Q 10 or oxidized coenzyme Q 10, water-soluble organic solvent, an oxidized coenzyme to implement the reduction reaction the Q 10 may be used for what it was converted to reduced coenzyme Q 10. Moreover, coenzyme Q 10 solution used in the production method of the present invention (A) is made of a coenzyme Q 10 and a water-soluble organic solvent containing the reduced coenzyme Q 10, the granules formed Other components may be included in an amount that does not interfere with the above.
本発明の製造方法において、水溶性有機溶媒の水溶液(B)の水溶性有機溶媒と水の混合比としては、特に制限されない。しかしながら、水溶性有機溶媒の水溶液(B)の水溶性有機溶媒の濃度が低い場合には、缶壁や攪拌軸等へのスケーリング量が若干増加し、また、数mm超の大きい粒子が得られやすい傾向があり、一方、水溶性有機溶媒の濃度が高い場合には、析出する造粒体の粒子径が小さくなり、得られる造粒体の流動性等の粉体物性が多少悪くなる傾向にある。この観点から、水溶性有機溶媒の水溶液(B)における水溶性有機溶媒の濃度は、約60〜95重量%の範囲が好ましいが、適当な粒子径を得る観点からは、より好ましくは約65重量%以上、さらに好ましくは約70重量%以上であり、また、より好ましくは約90重量%以下、さらに好ましくは約85重量%以下である。また、水溶性有機溶媒の水溶液(B)中に、造粒体形成を妨げない範囲で他の水溶性の成分を若干量含んでいても構わない。 In the production method of the present invention, the mixing ratio of the water-soluble organic solvent and water in the aqueous solution (B) of the water-soluble organic solvent is not particularly limited. However, when the concentration of the water-soluble organic solvent in the aqueous solution (B) of the water-soluble organic solvent is low, the amount of scaling to the can wall and the stirring shaft is slightly increased, and large particles exceeding several mm are obtained. On the other hand, when the concentration of the water-soluble organic solvent is high, the particle size of the granulated material to be precipitated tends to be small, and the powder physical properties such as fluidity of the resulting granulated material tend to be somewhat worse. is there. From this viewpoint, the concentration of the water-soluble organic solvent in the aqueous solution (B) of the water-soluble organic solvent is preferably in the range of about 60 to 95% by weight, but more preferably about 65% by weight from the viewpoint of obtaining an appropriate particle size. % Or more, more preferably about 70% by weight or more, more preferably about 90% by weight or less, and still more preferably about 85% by weight or less. In addition, the aqueous solution (B) of the water-soluble organic solvent may contain a small amount of other water-soluble components as long as the granule formation is not hindered.
本発明においては、上記補酵素Q10溶液(A)を、上記水溶性有機溶媒の水溶液(B)に添加することによって、補酵素Q10粒子を製造する。その補酵素Q10溶液(A)を水溶性有機溶媒の水溶液(B)に添加する工程、すなわち造粒工程について、以下説明する。 In the present invention, the coenzyme Q 10 solution (A), by adding to the aqueous solution (B) of the water-soluble organic solvent, to produce coenzyme Q 10 particles. Adding the coenzyme Q 10 solution (A) in an aqueous solution of a water-soluble organic solvent (B), that is, the granulation step will be described below.
上記造粒工程における補酵素Q10溶液(A)の温度としては、補酵素Q10が所定濃度で水溶性有機溶媒に溶解しておればよく、使用する水溶性有機溶媒の種類や量により異なるため、特に制限されないが、添加時の補酵素Q10溶液(A)の温度は、好ましくは約40℃以上、より好ましくは約45℃以上であり、また、好ましくは約70℃以下、より好ましくは約60℃以下である。 The temperature of the coenzyme Q 10 solution (A) in the granulation step, it is sufficient coenzyme Q 10 is dissolved in a water-soluble organic solvent at a predetermined concentration, varies depending on the kind and amount of the water-soluble organic solvent used Therefore, although not particularly limited, the temperature of the coenzyme Q 10 solution upon addition (a) is preferably from about 40 ° C. or more, more preferably about 45 ° C. or more, and less preferably about 70 ° C., and more preferably Is about 60 ° C. or less.
造粒工程における水溶性有機溶媒の水溶液(B)の温度としては、補酵素Q10溶液(A)の水溶性有機溶媒の種類や量、水溶性有機溶媒の水溶液(B)の水溶性有機溶媒の種類等にもよるが、25℃以下の範囲である必要がある。微粒子の生成を抑制する、収率を高める等の観点からは、上記温度は低いほど好ましく、約20℃以下がより好ましい。造粒工程での温度の下限は、系の固化温度となるが、好ましくは−10℃以上、より好ましくは約−5℃以上、特に好ましくは約0℃以上である。 The temperature of the aqueous solution of the water-soluble organic solvent in the granulating step (B), water-soluble organic solvent of the type and amount of the water-soluble organic solvent of coenzyme Q 10 solution (A), aqueous solution of a water-soluble organic solvent (B) Although it depends on the type and the like, it must be in the range of 25 ° C. or lower. From the viewpoint of suppressing the production of fine particles and increasing the yield, the temperature is preferably as low as possible, and more preferably about 20 ° C. or less. The lower limit of the temperature in the granulation step is the solidification temperature of the system, but is preferably −10 ° C. or higher, more preferably about −5 ° C. or higher, and particularly preferably about 0 ° C. or higher.
造粒工程における補酵素Q10溶液(A)の添加(滴下)方法としては特に制限されず、水溶性有機溶媒の水溶液(B)の上部から補酵素Q10溶液(A)を添加(滴下)しても良いし、水溶性有機溶媒の水溶液(B)内にノズルを導入し、補酵素Q10溶液(A)を該水溶性有機溶媒の水溶液(B)に直接添加しても良い。しかしながら、微細な粒子の生成を抑制するという観点からは、水溶性有機溶媒の水溶液(B)の上部から補酵素Q10溶液(A)を添加(滴下)するのが好ましい。 The addition of coenzyme Q 10 solution in the granulation step (A) (dropwise) is not particularly limited as method, an aqueous solution of a water-soluble organic solvent (B) adding coenzyme Q 10 solution (A) from the top of the (dropping) may be, by introducing nozzle into the aqueous solution of a water-soluble organic solvent (B), coenzyme Q 10 solution (a) may be added directly to the water-soluble organic solvent of the aqueous solution (B). However, from the viewpoint of suppressing the generation of fine particles, preferably from the top of an aqueous solution of a water-soluble organic solvent (B) to add coenzyme Q 10 solution (A) (dropwise).
尚、造粒槽内の温度等の条件によっては、補酵素Q10溶液(A)の滴下と同時に固化(造粒)が進行しうるが、その場合も特に支障はない。 Depending on the conditions such as the temperature of the granulation tank, dropwise and simultaneously solidified coenzyme Q 10 solution (A) (Granulation) but may proceed, there is no particular problem even if the.
上記造粒工程は、普通、強制流動下に実施するのが好ましい。目的とする補酵素Q10粒子の粒径等によっても異なるが、普通は、単位容積当たりの撹拌所要動力として、好ましくは約0.01kW/m3以上、より好ましくは約0.1kW/m3以上、さらに好ましくは約0.3kW/m3以上の条件で実施する。上記の強制流動は、通常、撹拌翼の回転により与えられるが、上記流動が得られれば必ずしも撹拌翼を用いる必要はなく、例えば、液の循環による方法などを利用する方法も考え得る。 The granulation step is usually preferably carried out under forced flow. Usually, the required power for stirring per unit volume is preferably about 0.01 kW / m 3 or more, more preferably about 0.1 kW / m 3 , although it depends on the particle size of the target coenzyme Q 10 particles. As mentioned above, it implements on the conditions of about 0.3 kW / m < 3 > or more more preferably. The forced flow is usually given by the rotation of a stirring blade, but it is not always necessary to use the stirring blade as long as the flow is obtained. For example, a method using a method of circulating liquid may be considered.
造粒工程時の上記補酵素Q10溶液(A)の添加(滴下)速度は、特に制限されないが、例えば、単位時間(1時間)当たり補酵素Q10溶液(A)の全量が添加(滴下)される速度(100%量/時間)以下とするのが好ましく、より好ましくは、単位時間当たり補酵素Q10溶液(A)の約50%量が添加(滴下)される速度(50%量/時間)以下、さらに好ましくは、単位時間当たり補酵素Q10溶液(A)の約25%量が添加(滴下)される速度(25%量/時間)以下である。 Addition of granulation step when the coenzyme Q 10 solution (A) (dropping) rate is not particularly limited, for example, the total amount is added in a unit time (1 hour) per coenzyme Q 10 solution (A) (dropwise ) it is preferable to be less than the speed (100% weight / time) is, more preferably, the rate (50% weight to about 50% weight per unit of time coenzyme Q 10 solution (a) is added (dropwise) / hour) or less, more preferably, the rate of about 25% weight per unit of time coenzyme Q 10 solution (a) is added (dropwise) (25% weight / hour) or less.
造粒工程における系全体に対する補酵素Q10の濃度は、特に制限はないが、一般に、補酵素Q10溶液(A)を水溶性有機溶媒の水溶液(B)に添加し終わった時点での全組成物(すなわち補酵素Q10溶液(A)と水溶性有機溶媒の水溶液(B)の総和)に対する補酵素Q10の濃度として、好ましくは約50重量%以下、より好ましくは約40重量%以下、さらに好ましくは約30重量%以下となるように調整する。系全体に対する補酵素Q10の濃度の下限は、特に制限されないが、生産性の観点から、補酵素Q10の濃度は通常、約1重量%以上であり、好ましくは約2重量%以上である。 Concentration of coenzyme Q 10 for the entire system in the granulation step is not particularly limited, in general, at the time had been added coenzyme Q 10 solution (A) in an aqueous solution of a water-soluble organic solvent (B) total as the concentration of coenzyme Q 10 for the composition (sum of i.e. coenzyme Q 10 solution (a) and the water-soluble organic solvent in an aqueous solution (B)), preferably from about 50 wt% or less, more preferably less than about 40 wt% More preferably, the content is adjusted to about 30% by weight or less. The lower limit of the concentration of coenzyme Q 10 for the entire system is not particularly limited, from the viewpoint of productivity, the concentration of coenzyme Q 10 is usually about 1 wt% or more, preferably about 2 wt% or more .
造粒工程時の造粒系(水溶性有機溶媒の水溶液(B)と添加された補酵素Q10溶液(A)の混合物)における水溶性有機溶媒と水の重量比は特に制限されないが、造粒系全体における水溶性有機溶媒の濃度は、約60〜95重量%の範囲が好ましく、より好ましくは約65重量%以上、さらに好ましくは約70重量%以上であり、また、より好ましくは約90重量%以下、さらに好ましくは約85重量%以下である。造粒工程中、補酵素Q10溶液(A)を水溶性有機溶媒の水溶液(B)に添加することにより、造粒系に対する水溶性有機溶媒の濃度は増加するが、それでも上記好ましい範囲内となるように、予め、補酵素Q10溶液(A)と水溶性有機溶媒の水溶液(B)の量比や水溶性有機溶媒の水溶液(B)の水溶性有機溶媒濃度を決定しても良いし、造粒系の水溶性有機溶媒と水との重量比を一定に保つために、造粒時に別途水を添加しても良い。 Granulating step when the granulation system the weight ratio of the water-soluble organic solvent and water in (a mixture of an aqueous solution of a water-soluble organic solvent (B) is added and the coenzyme Q 10 solution (A)) is not particularly limited, concrete The concentration of the water-soluble organic solvent in the whole grain system is preferably in the range of about 60 to 95% by weight, more preferably about 65% by weight or more, further preferably about 70% by weight or more, and more preferably about 90% by weight. % By weight or less, more preferably about 85% by weight or less. During the granulation step, by adding coenzyme Q 10 solution (A) in an aqueous solution of a water-soluble organic solvent (B), the concentration of the water-soluble organic solvent for granulation system increases, but still a within the above preferred ranges so that, in advance, it may be determined a water-soluble organic solvent concentration of ratio or a water-soluble organic solvent in an aqueous solution of coenzyme Q 10 solutions (a) and the water-soluble organic solvent in an aqueous solution (B) (B) In order to keep the weight ratio of the granulated water-soluble organic solvent and water constant, water may be added separately during granulation.
一方、造粒時に数十μm程度以下の微粒子が生成した場合には、造粒終了時の該系中に水溶性有機溶媒を加え、生成した微粒子を溶解させても良いし、微粒子の生成量が多い場合には、水溶性有機溶媒を加えることが好ましい。 On the other hand, when fine particles of about several tens of μm or less are produced during granulation, a water-soluble organic solvent may be added to the system at the end of granulation to dissolve the produced fine particles. When there is much, it is preferable to add a water-soluble organic solvent.
このようにして得られる補酵素Q10粒子(造粒体)は、好ましくは、例えば、遠心分離、加圧濾過、減圧濾過等による固液分離、更に、必要に応じてケーキ洗浄を行い、更に、減圧乾燥(真空乾燥)により乾体として取得することができるし、乾体として取得するのが好ましい。 The thus obtained coenzyme Q 10 particles (granulated material) are preferably subjected to solid-liquid separation by, for example, centrifugation, pressure filtration, vacuum filtration, etc., and cake washing is performed as necessary. It can be obtained as a dry body by drying under reduced pressure (vacuum drying), and is preferably obtained as a dry body.
また、得られた造粒体は、粒子径をより均一なものとするために、必要に応じ、篩等を用いて、分級しても良い。 Moreover, in order to make a particle diameter more uniform, the obtained granule may be classified using a sieve or the like, if necessary.
還元型補酵素Q10は空気酸素により容易に酸化されるため、本発明の製造工程における一連の操作は、脱酸素雰囲気下で実施することが好ましい。脱酸素雰囲気は、不活性ガスによる置換、減圧、沸騰やこれらを組み合わせることにより達成できる。少なくとも、不活性ガスによる置換、即ち、不活性ガス雰囲気を用いるのが好適である。上記不活性ガスとしては、例えば、窒素ガス、ヘリウムガス、アルゴンガス、水素ガス、炭酸ガス等を挙げることができ、好ましくは窒素ガスである。 Since reduced coenzyme Q 10 is readily oxidized by atmospheric oxygen, a series of operations in the production process of the present invention is preferably carried out under an oxygen atmosphere. The deoxygenated atmosphere can be achieved by substitution with an inert gas, reduced pressure, boiling, or a combination thereof. It is preferable to use at least substitution with an inert gas, that is, an inert gas atmosphere. Examples of the inert gas include nitrogen gas, helium gas, argon gas, hydrogen gas, carbon dioxide gas, and the like, preferably nitrogen gas.
本発明の製造方法により、工業的規模での生産に適した方法で、攪拌翼や缶壁へのスケーリングを起こすことなく、約100〜1000μm程度の均一でかつ適当な粒子径を持ち、さらに、食品、栄養機能食品、特定保健用食品、栄養補助剤、栄養剤、動物薬、飲料、飼料、化粧品、医薬品、治療薬、予防薬等に加工しやすい固さの、還元型補酵素Q10を含有する補酵素Q10粒子を製造することができる。 With the production method of the present invention, it is a method suitable for production on an industrial scale, and has a uniform and appropriate particle size of about 100 to 1000 μm without causing scaling to a stirring blade or can wall, food, food with nutrient function claims, food for specified health use, nutritional supplement, nutritional, animal drug, drink, feed, cosmetics, pharmaceuticals, therapeutic agents, the workable firmness in prophylactic etc., the reduced coenzyme Q 10 Coenzyme Q 10 particles can be produced.
以下に製造例、実施例を挙げて本発明をさらに詳しく説明するが、本発明はこれらに限定されるものではない。なお、下記実施例において使用した酸化型補酵素Q10は、株式会社カネカ製のもの(純度99.5%)を使用した。また、酸化型補酵素Q10や還元型補酵素Q10の純度、還元型補酵素Q10/酸化型補酵素Q10の比率(重量比)は下記HPLC分析により求めた。 Hereinafter, the present invention will be described in more detail with reference to production examples and examples, but the present invention is not limited thereto. Incidentally, oxidized coenzyme Q 10 used in the following examples, were used those manufactured by Kaneka Corporation (purity 99.5%). Further, the purity of the oxidized coenzyme Q 10 and reduced coenzyme Q 10, the ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 (weight ratio) was determined by the following HPLC analysis.
(HPLC分析条件)
カラム:SYMMETRY C18(Waters製)250mm(長さ)4.6mm(内径)、移動相;C2H5OH:CH3OH=4:3(v:v)、検出波長;210nm、流速;1ml/min、還元型補酵素Q10の保持時間;9.1min、酸化型補酵素Q10の保持時間;13.3min。
(HPLC analysis conditions)
Column: SYMMETRY C18 (manufactured by Waters) 250 mm (length) 4.6 mm (inner diameter), mobile phase; C 2 H 5 OH: CH 3 OH = 4: 3 (v: v), detection wavelength: 210 nm, flow rate: 1 ml / min, reduced coenzyme retention time of the enzyme Q 10; 9.1min, retention time of oxidized coenzyme Q 10; 13.3min.
(実施例1)
1000gのエタノール中に、100gの酸化型補酵素Q10、60gのL−アスコルビン酸を加え、78℃にて攪拌し、還元反応を行った。30時間後、50℃まで冷却し、同温を保持しながらヘキサン1000gと脱気した水1000gを加えた。25℃まで冷却後、水相を除去し、さらに脱気した飽和食塩水1000gで6回水洗し、水相を除去した。なお、以上すべての操作は窒素雰囲気下にて実施した。このヘキサン溶液から、48℃、減圧下にてヘキサンを留去し、油状物の還元型補酵素Q10(約100g)を得た。得られた還元型補酵素Q10に、エタノール100gを加え、50℃にて溶解させた。この還元型補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度80重量%エタノール水溶液1000g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、さらに冷エタノール、冷水、冷エタノールで順に洗浄(洗浄に用いた冷溶媒の温度は2℃)して、さらに、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体97gを得た(有姿収率97モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.5/0.5、還元型補酵素Q10の純度は99.2%であった。また、得られた造粒体の90%が直径約200〜700μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
Example 1
In 1000 g of ethanol, 100 g of oxidized coenzyme Q 10 and 60 g of L-ascorbic acid were added and stirred at 78 ° C. to carry out a reduction reaction. After 30 hours, the mixture was cooled to 50 ° C., and 1000 g of hexane and 1000 g of degassed water were added while maintaining the same temperature. After cooling to 25 ° C., the aqueous phase was removed, and further washed with 1000 g of deaerated saturated brine 1000 times to remove the aqueous phase. All the above operations were performed under a nitrogen atmosphere. From this hexane solution, hexane was distilled off at 48 ° C. under reduced pressure to obtain an oily reduced coenzyme Q 10 (about 100 g). To the resulting reduced coenzyme Q 10, the ethanol 100g added and dissolved at 50 ° C.. The reduced coenzyme Q 10 / ethanol solution is dropped into 1000 g of 80 wt% ethanol aqueous solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 . gave a coenzyme Q 10 granule. The granulated product was filtered under reduced pressure, further washed with cold ethanol, cold water, and cold ethanol in this order (the temperature of the cold solvent used for washing was 2 ° C.), and further dried under reduced pressure (20-40 ° C., 1-30 mmHg). by to yield a white coenzyme Q 10 granules 97 g (Yusugata yield 97 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.5 / 0.5, and the purity of reduced coenzyme Q 10 was 99.2%. Moreover, 90% of the obtained granulated material was granular having a diameter of about 200 to 700 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例2)
使用するエタノール水溶液を、濃度70重量%のものに変更した以外は、すべて実施例1と同様の方法で還元・造粒を行うことにより、補酵素Q10の造粒体98gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.5/0.5、還元型補酵素Q10の純度は99.2%であった。また得られた造粒体の85%が直径約300〜1000μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 2)
The aqueous ethanol solution to be used, except for changing the intended concentration of 70 wt%, by performing the reduction and granulation in all the same manner as in Example 1 to obtain a granulated body 98g of coenzyme Q 10 (Yes Appearance yield 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.5 / 0.5, and the purity of reduced coenzyme Q 10 was 99.2%. Moreover, 85% of the obtained granulated body was a granule having a diameter of about 300 to 1000 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例3)
使用するエタノール水溶液を、濃度90重量%のものに変更した以外は、すべて実施例1と同様の方法で還元・造粒を行うことにより、補酵素Q10の造粒体97gを得た(有姿収率97モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.5/0.5、還元型補酵素Q10の純度は99.2%であった。また、得られた造粒体の80%が直径約100〜500μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 3)
Except that the aqueous ethanol solution used was changed to one having a concentration of 90% by weight, 97 g of granulated body of coenzyme Q10 was obtained by performing reduction and granulation in the same manner as in Example 1 (solid) Yield 97 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.5 / 0.5, and the purity of reduced coenzyme Q 10 was 99.2%. Further, 80% of the obtained granulated body was a granule having a diameter of about 100 to 500 μm, and it was hard enough to be easily broken by pressing with a finger.
(比較例1)
1000gのエタノール中に、100gの酸化型補酵素Q10、60gのL−アスコルビン酸を加え、78℃にて攪拌し、還元反応を行った。30時間後、50℃まで冷却し、同温を保持しながらヘキサン1000gと脱気した水1000gを加えた。25℃まで冷却後、水相を除去し、さらに脱気した飽和食塩水1000gで6回水洗し、水相を除去した。なお、以上すべての操作は窒素雰囲気下にて実施した。このヘキサン溶液から、48℃、減圧下にてヘキサンを留去し、油状物の還元型補酵素Q10を得た。この油状物を、窒素雰囲気下で2℃の濃度50重量%エタノール水溶液1000g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、還元型補酵素Q10を結晶化させた。得られた結晶を減圧ろ過し、湿結晶を冷エタノール、冷水、冷エタノールで順に洗浄(洗浄に用いた冷溶媒の温度は2℃)して、さらに、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の乾燥結晶93gを得た(有姿収率93モル%)。得られた結晶の90%程度が直径約1.5〜2mmの粒状であり、還元型補酵素Q10/酸化型補酵素Q10の重量比は99.5/0.5、還元型補酵素Q10の純度は99.2%であり、指で押さえるだけでは容易に崩れない固さであった。
(Comparative Example 1)
In 1000 g of ethanol, 100 g of oxidized coenzyme Q 10 and 60 g of L-ascorbic acid were added and stirred at 78 ° C. to carry out a reduction reaction. After 30 hours, the mixture was cooled to 50 ° C., and 1000 g of hexane and 1000 g of degassed water were added while maintaining the same temperature. After cooling to 25 ° C., the aqueous phase was removed, and further washed with 1000 g of deaerated saturated brine 1000 times to remove the aqueous phase. All the above operations were performed under a nitrogen atmosphere. From this hexane solution, 48 ° C., distilling off hexane under reduced pressure to give reduced coenzyme Q 10 oil. This oily substance was dropped into 1000 g of a 50 wt% ethanol aqueous solution at 2 ° C. under a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3, thereby reducing reduced coenzyme Q. 10 was crystallized. The obtained crystals were filtered under reduced pressure, and the wet crystals were washed with cold ethanol, cold water and cold ethanol in this order (the temperature of the cold solvent used for washing was 2 ° C.) and further dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 93 g of white dry crystals (solid yield 93 mol%). About 90% of the obtained crystals are granular having a diameter of about 1.5 to 2 mm, and the weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 is 99.5 / 0.5. the purity of the Q 10 was 99.2%, and hardness is do not readily collapse simply pressing with a finger.
(実施例4)
比較例1で得られた結晶(還元型補酵素Q1099.2%)10gを、50℃にて10gのアセトンに溶解させた。この補酵素Q10/アセトン溶液を、窒素雰囲気下、2℃の濃度70重量%アセトン水溶液溶液100g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.4/0.6、還元型補酵素Q10の純度は99.1%であった。また、得られた造粒体の60%が直径約100〜400μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
Example 4
10 g of the crystals (reduced coenzyme Q 10 99.2%) obtained in Comparative Example 1 were dissolved in 10 g of acetone at 50 ° C. By dropping this coenzyme Q 10 / acetone solution into 100 g of a 70 wt% acetone aqueous solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 . to obtain a coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of white coenzyme Q 10 granulated product (solid yield: 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.4 / 0.6, and the purity of reduced coenzyme Q 10 was 99.1%. Moreover, 60% of the obtained granulated body was a granule having a diameter of about 100 to 400 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例5)
比較例1で得られた結晶(還元型補酵素Q1099.2%)10gを50℃にて10gのエタノールに溶解させた。この補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度80重量%エタノール水溶液100g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.4/0.6、還元型補酵素Q10の純度は99.1%であった。また、得られた造粒体の90%が直径約100〜600μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 5)
10 g of the crystals (reduced coenzyme Q 10 99.2%) obtained in Comparative Example 1 were dissolved in 10 g of ethanol at 50 ° C. By dropping this coenzyme Q 10 / ethanol solution into 100 g of 80 wt% ethanol aqueous solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 , It was obtained coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of white coenzyme Q 10 granulated product (solid yield: 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.4 / 0.6, and the purity of reduced coenzyme Q 10 was 99.1%. In addition, 90% of the obtained granulated body was granular having a diameter of about 100 to 600 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例6)
比較例1で得られた結晶(還元型補酵素Q1099.2%)10gを50℃にて10gのアセトンに溶解させた。この補酵素Q10/アセトン溶液を、窒素雰囲気下、2℃の濃度85重量%エタノール水溶液溶液100g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.4/0.6、還元型補酵素Q10の純度は99.1%であった。また、得られた造粒体の90%が直径約100〜600μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 6)
10 g of the crystals (reduced coenzyme Q 10 99.2%) obtained in Comparative Example 1 were dissolved in 10 g of acetone at 50 ° C. By dropping this coenzyme Q 10 / acetone solution into 100 g of an aqueous 85 wt% ethanol solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 . to obtain a coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of white coenzyme Q 10 granulated product (solid yield: 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.4 / 0.6, and the purity of reduced coenzyme Q 10 was 99.1%. In addition, 90% of the obtained granulated body was granular having a diameter of about 100 to 600 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例7)
酸化型補酵素Q105gと比較例1で得られた結晶(還元型補酵素Q1099.2%)5gを、60℃にて10gのエタノールに溶解させた。この補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度85重量%エタノール水溶液500g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、黄色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は49.4/50.6であった。また、得られた造粒体の70%が直径約100〜600μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 7)
5 g of oxidized coenzyme Q 10 and 5 g of the crystals obtained in Comparative Example 1 (reduced coenzyme Q 10 99.2%) were dissolved in 10 g of ethanol at 60 ° C. By dropping this coenzyme Q 10 / ethanol solution into 500 g of an aqueous 85 wt% ethanol solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 , It was obtained coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of a yellow coenzyme Q 10 granulated product (solid yield 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 in the obtained granule was 49.4 / 50.6. Moreover, 70% of the obtained granulated body was a granule having a diameter of about 100 to 600 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例8)
酸化型補酵素Q104.5gと比較例1で得られた結晶(還元型補酵素Q1099.2%)0.5gを、60℃にて10gのエタノールに溶解させた。この補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度85重量%エタノール水溶液500g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、橙色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は9.7/90.3であった。また、得られた造粒体の70%が直径約100〜700μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 8)
4.5 g of oxidized coenzyme Q 10 and 0.5 g of the crystals obtained in Comparative Example 1 (reduced coenzyme Q 10 99.2%) were dissolved in 10 g of ethanol at 60 ° C. By dropping this coenzyme Q 10 / ethanol solution into 500 g of an aqueous 85 wt% ethanol solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 , It was obtained coenzyme Q 10 granulation body. The granulated body was filtered under reduced pressure, vacuum drying (20 to 40 ° C., 1~30MmHg) by to afford the coenzyme Q 10 granules 9.8g orange (Yusugata 98 mole% yield). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 in the obtained granule was 9.7 / 90.3. Further, 70% of the obtained granulated body was granular having a diameter of about 100 to 700 μm, and it was hard enough to be easily broken by pressing with a finger.
(比較例2)
酸化型補酵素Q1010gを50℃にて130gのエタノールに溶解させた。この酸化型補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度80重量%エタノール水溶液200g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下したところ、酸化型補酵素Q10の結晶が得られた。この結晶を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、橙色の酸化型補酵素Q10結晶9.8gを得た(有姿収率98モル%)。また、得られた結晶の90%が直径約10μm程度での非常に細かい結晶であった。
(Comparative Example 2)
10 g of oxidized coenzyme Q 10 was dissolved in 130 g of ethanol at 50 ° C. When this oxidized coenzyme Q 10 / ethanol solution was dropped into 200 g of an 80 wt% ethanol aqueous solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 . , crystal of oxidized coenzyme Q 10 was obtained. The crystals were filtered under reduced pressure, vacuum drying (20 to 40 ° C., 1~30MmHg) by to afford the oxidized coenzyme Q 10 crystal 9.8g orange (Yusugata 98 mole% yield). In addition, 90% of the obtained crystals were very fine crystals having a diameter of about 10 μm.
(実施例9)
比較例1で得られた結晶(還元型補酵素Q1099.2%)10gを60℃にて2.5gのエタノールに溶解させた。この補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度85重量%エタノール水溶液200g中に、攪拌所要動力0.3kW/m3にて攪拌しながら1時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.4/0.6、還元型補酵素Q10の純度は99.1%であった。また、得られた造粒体の90%が直径約100〜700μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
Example 9
10 g of the crystals (reduced coenzyme Q 10 99.2%) obtained in Comparative Example 1 were dissolved in 2.5 g of ethanol at 60 ° C. By dropping this coenzyme Q 10 / ethanol solution into 200 g of 85 wt% ethanol aqueous solution at 2 ° C. in a nitrogen atmosphere over 1 hour while stirring at a required power of stirring of 0.3 kW / m 3 , It was obtained coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of white coenzyme Q 10 granulated product (solid yield: 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.4 / 0.6, and the purity of reduced coenzyme Q 10 was 99.1%. In addition, 90% of the obtained granulated material was granular having a diameter of about 100 to 700 μm, and it was hard enough to be easily broken by pressing with a finger.
(実施例10)
比較例1で得られた結晶(還元型補酵素Q1099.2%)10gを50℃にて23gのエタノールに溶解させた。この補酵素Q10/エタノール溶液を、窒素雰囲気下、2℃の濃度75重量%エタノール水溶液200g中に、攪拌所要動力0.3kW/m3にて攪拌しながら2時間かけて滴下することにより、補酵素Q10造粒体を得た。この造粒体を減圧ろ過し、減圧乾燥(20〜40℃、1〜30mmHg)することにより、白色の補酵素Q10造粒体9.8gを得た(有姿収率98モル%)。得られた造粒体の還元型補酵素Q10/酸化型補酵素Q10の重量比は99.4/0.6、還元型補酵素Q10の純度は99.1%であった。また、得られた造粒体の70%が直径約100〜400μm程度の粒状であり、指で押さえるだけで簡単に崩れる固さであった。
(Example 10)
10 g of the crystals (reduced coenzyme Q 10 99.2%) obtained in Comparative Example 1 were dissolved in 23 g of ethanol at 50 ° C. By dropping the coenzyme Q 10 / ethanol solution into 200 g of a 75 wt% ethanol aqueous solution at 2 ° C. in a nitrogen atmosphere over 2 hours while stirring at a required power of stirring of 0.3 kW / m 3 , It was obtained coenzyme Q 10 granulation body. The granulated product was filtered under reduced pressure and dried under reduced pressure (20 to 40 ° C., 1 to 30 mmHg) to obtain 9.8 g of white coenzyme Q 10 granulated product (solid yield: 98 mol%). The weight ratio of reduced coenzyme Q 10 / oxidized coenzyme Q 10 of the obtained granule was 99.4 / 0.6, and the purity of reduced coenzyme Q 10 was 99.1%. Further, 70% of the obtained granulated body was granular having a diameter of about 100 to 400 μm, and it was hard enough to be easily broken by pressing with a finger.
Claims (8)
25℃以下の水溶性有機溶媒の水溶液(B)中に、
添加することを特徴とする補酵素Q10粒子の製造方法であって、
補酵素Q 10 溶液(A)に使用する水溶性有機溶媒がエタノール及び/又はアセトンであり、水溶性有機溶媒の水溶液(B)に使用する水溶性有機溶媒がエタノール及び/又はアセトンである、補酵素Q 10 粒子の製造方法。 And coenzyme Q 10 30 to 80 wt% containing reduced coenzyme Q 10, coenzyme Q 10 solution consisting of 70 to 20% by weight of a water-soluble organic solvent (A),
In an aqueous solution (B) of a water-soluble organic solvent at 25 ° C. or lower,
A method for producing coenzyme Q 10 particles , comprising:
The water-soluble organic solvent used for the coenzyme Q 10 solution (A) is ethanol and / or acetone, and the water-soluble organic solvent used for the aqueous solution (B) of the water-soluble organic solvent is ethanol and / or acetone. Method for producing enzyme Q 10 particles .
The process according to any one of claims 1 to 7 carried out under deoxygenated atmosphere.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007032319A JP5159117B2 (en) | 2007-02-13 | 2007-02-13 | Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007032319A JP5159117B2 (en) | 2007-02-13 | 2007-02-13 | Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008195650A JP2008195650A (en) | 2008-08-28 |
| JP5159117B2 true JP5159117B2 (en) | 2013-03-06 |
Family
ID=39754935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007032319A Active JP5159117B2 (en) | 2007-02-13 | 2007-02-13 | Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5159117B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7739411B2 (en) * | 2021-03-26 | 2025-09-16 | 株式会社カネカ | Form II reduced coenzyme Q10 crystals or crystalline solids thereof, and crystallization apparatus |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4170657B2 (en) * | 2001-07-13 | 2008-10-22 | 株式会社カネカ | Crystallization of reduced coenzyme Q10 |
-
2007
- 2007-02-13 JP JP2007032319A patent/JP5159117B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008195650A (en) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3790530B2 (en) | Stabilization of reduced coenzyme Q10 | |
| JP4057523B2 (en) | Method for producing reduced coenzyme Q10 using a solvent having a high oxidation protection effect | |
| CA2837695C (en) | Reduced coenzyme q10 crystal having excellent stability | |
| WO2007126083A1 (en) | Method for stabilization of reduced coenzyme q10 | |
| JPWO2007126086A1 (en) | Purification method of reduced coenzyme Q10 | |
| JP4598873B2 (en) | Method for producing reduced coenzyme Q10 using hydrous organic solvent | |
| JP2003089669A (en) | Crystallization method of reduced coenzyme Q10 | |
| JP5159117B2 (en) | Method for producing coenzyme Q10 particles containing reduced coenzyme Q10 | |
| JP3867927B2 (en) | Stabilization of reduced coenzyme Q10 | |
| JP4220565B2 (en) | Method for producing reduced coenzyme Q10 using a solvent having a high oxidation protection effect | |
| JP3892881B2 (en) | Stabilization of reduced coenzyme Q10 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091221 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120904 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121105 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121211 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121211 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5159117 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151221 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151221 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151221 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |